Fig. 6.
Fig. 6. Sequential dilution expansion (Delta assay) of AdGFP-infected CD34+ cells in the presence of IL-3, IL-6, G-CSF, KL, and EPO. Increasing concentrations of AdGFP (MOI of 0 to 1,000) used for infection of CD34+ cells before expansion did not impair the proliferative capacity of the cells. In all conditions, the cells cumulatively expanded by 3 log. The cumulative number of GFP-expressing progeny derived from AdGFP-infected CD34+ cells was measured throughout the expansion culture. If MOIs >100 were used for infection of CD34+cells, moderate expansion (1 log) of GFP+ progeny was observed. However, with lower MOIs (<100) used for infection, the number of GFP+ progeny did not proportionally increase during expansion.

Sequential dilution expansion (Delta assay) of AdGFP-infected CD34+ cells in the presence of IL-3, IL-6, G-CSF, KL, and EPO. Increasing concentrations of AdGFP (MOI of 0 to 1,000) used for infection of CD34+ cells before expansion did not impair the proliferative capacity of the cells. In all conditions, the cells cumulatively expanded by 3 log. The cumulative number of GFP-expressing progeny derived from AdGFP-infected CD34+ cells was measured throughout the expansion culture. If MOIs >100 were used for infection of CD34+cells, moderate expansion (1 log) of GFP+ progeny was observed. However, with lower MOIs (<100) used for infection, the number of GFP+ progeny did not proportionally increase during expansion.

Close Modal

or Create an Account

Close Modal
Close Modal